Bureau N J, Moser T, Dagher J H, Shedid D, Li M, Brassard P, Leduc B E
From the Department of Radiology (N.J.B., T.M.)Research Center (N.J.B., T.M.)
From the Department of Radiology (N.J.B., T.M.)Research Center (N.J.B., T.M.).
AJNR Am J Neuroradiol. 2014 Aug;35(8):1467-74. doi: 10.3174/ajnr.A4026. Epub 2014 May 29.
Transforaminal corticosteroid injections can be performed in the management of cervical radiculopathy but carry the risk of catastrophic complications. This study compares the efficacy of transforaminal and facet corticosteroid injections at 4 weeks' follow-up.
We randomly assigned 56 subjects to receive CT-guided transforaminal (15 men, 13 women; mean age, 52 years; range, 28-72 years) or facet (8 men, 20 women; mean, 44 years; range, 26-60 years) injections. The primary outcome was pain severity rated on a Visual Analog Scale (0-100). Secondary outcomes were the Neck Disability Index and the Medication Quantitative Scale.
In the intention-to-treat and as-treated analyses, for a mean baseline score, facet injections demonstrated a significant pain score reduction of 45.3% (95% CI, 21.4-69.2) and 37.0% (95% CI, 9.2-64.7), while transforaminal injections showed a nonsignificant pain score reduction of 9.8% (95% CI, +11.5-31.2) and 17.8% (95% CI, +6.6-42.2). While facet injections demonstrated an improvement in the Neck Disability Index score of 24.3% (95% CI, +2.9-51.5) and 20.7% (95% CI, +6.2-47.6) as opposed to transforaminal injections of 9.6% (95% CI, +15.2-34.4) and 12.8% (95% CI, +11.2-36.7), the results were not statistically significant. Noninferiority of facet to transforaminal injections was demonstrated for baseline pain scores of ≤60, while noninferiority analysis was inconclusive for baseline pain scores of ≥80 and for the Neck Disability Index. Neither intervention showed a significant medication-intake score reduction with time.
Facet injections are effective for the treatment of cervical radiculopathy and represent a valid and safer alternative to transforaminal injections.
经椎间孔皮质类固醇注射可用于治疗神经根型颈椎病,但存在严重并发症的风险。本研究比较了经椎间孔和小关节皮质类固醇注射在4周随访时的疗效。
我们将56名受试者随机分为两组,分别接受CT引导下的经椎间孔注射(15名男性,13名女性;平均年龄52岁;范围28 - 72岁)或小关节注射(8名男性,20名女性;平均年龄44岁;范围26 - 60岁)。主要结局指标是视觉模拟评分法(0 - 100)评定的疼痛严重程度。次要结局指标是颈部功能障碍指数和药物定量量表。
在意向性分析和实际治疗分析中,对于平均基线评分,小关节注射的疼痛评分显著降低了45.3%(95%可信区间,21.4 - 69.2)和37.0%(95%可信区间,9.2 - 64.7),而经椎间孔注射的疼痛评分降低不显著,分别为9.8%(95%可信区间,+11.5 - 31.2)和17.8%(95%可信区间,+6.6 - 42.2)。小关节注射的颈部功能障碍指数评分改善了24.3%(95%可信区间,+2.9 - 51.5)和20.7%(95%可信区间,+6.2 - 47.6),与之相比,经椎间孔注射分别为9.6%(95%可信区间,+15.2 - 34.4)和12.8%(95%可信区间,+11.2 - 36.7),结果无统计学意义。对于基线疼痛评分≤60的情况,证明小关节注射不劣于经椎间孔注射,但对于基线疼痛评分≥80的情况以及颈部功能障碍指数,非劣效性分析尚无定论。两种干预措施均未显示随着时间推移药物摄入评分有显著降低。
小关节注射对神经根型颈椎病有效,是经椎间孔注射的一种有效且更安全的替代方法。